Press Releases Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Market Closed - NSE India S.E. Other stock markets 07:43:53 2024-05-15 am EDT			5-day change	1st Jan Change
997 ^INR	+1.36%		-0.85%	+44.67%

May. 13	Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets	MT
May. 10	India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says	RE

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals	May. 06	AQ
Zydus launches Mirabegron Extended-Release Tablets in the US	Apr. 22	BU
PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines	23-06-29	AQ
Zydus Lifesciences : Loss of Share Certificates	22-12-28	PU
Tetanus Pipeline Analysis: 20+ Companies are Working to Improve the Treatment Space \| DelveInsight	22-10-18	AQ
Hepatitis A Pipeline Landscape Analysis of 3+ Companies by DelveInsight	22-10-12	AQ
Zydus Lifesciences : General updates	22-10-07	PU
BridgeBio Pharma and Sentynl Therapeutics Receive Marketing Authorization in the EU for NULIBRY for the Treatment of MoCD Type A	22-09-21	AQ
Zydus Lifesciences : receives final approval from the USFDA for Lenalidomide Capsules 5 mg, 10 mg, 15 mg and 25 mg	22-09-13	PU
Zydus Lifesciences : receives final approval and 180 days shared exclusivity from the USFDA for Cariprazine Capsules	22-09-12	PU
Zydus Lifesciences : announces positive Phase 2 Proof-of-Concept of NLRP3 inhibitor, ZYIL1 in patients with Cryopyrin Associated Periodic Syndrome (CAPS)	22-09-07	PU
Zydus Lifesciences : announces Phase IV DREAM-CKD trial to generate Real World Evidence of Desidustat in patients with Chronic Kidney Disease induced anemia	22-08-30	PU
Zydus Lifesciences : Transcript of the 27th Annual General Meeting	22-08-27	PU
Zydus Lifesciences : Loss of share certificate	22-08-24	PU
Zydus Lifesciences : Q1 FY23 Earnings Call Transcript13 August 2022 Format	22-08-13	PU
Zydus Lifesciences : receives final approval from the USFDA for Prochlorperazine Maleate Tablets	22-08-12	PU
BridgeBio Pharma, Sentynl Therapeutics and Medison Pharma Announce Approval in Israel for NULIBRY (fosdenopterin) for the Treatment of MoCD Type A	22-08-11	AQ
Zydus Lifesciences : Earnings Call Audio Q1 FY23 – August 202210 August 2022 Format	22-08-10	PU
Zydus Lifesciences : Financial Performance for Q1 FY23	22-08-10	PU
Zydus Lifesciences : August 2022	22-08-10	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Press Releases

Filters